Introduction
Non-muscle-invasive bladder cancer (NMIBC) represents approximately 75% of all bladder cancer diagnoses. For decades, Transurethral Resection of the Bladder Tumor (TURBT) has served as the "gold standard" treatment. However, TURBT utilizes electrical current, which presents specific surgical risks. The most significant is the obturator nerve reflex—an involuntary leg jerk caused by electrical stimulation that can lead to bladder perforation. Furthermore, the thermal damage associated with electrocautery can prolong recovery.
This systematic review and meta-analysis investigates whether Holmium Laser Resection of the Bladder Tumor (HOLRBT) offers a safer and more effective alternative by utilizing laser energy instead of electricity.
Methods and Study Selection
The researchers conducted a systematic review following PRISMA guidelines, searching PubMed, the Cochrane Library, and Embase for studies comparing HOLRBT and TURBT published through March 2019.
The final analysis included 9 comparative studies (1 Randomized Controlled Trial, 3 prospective cohort studies, and 5 retrospective case-control studies) involving a total of 1,166 patients (473 HOLRBT; 693 TURBT). Statistical analysis was performed using Review Manager 5.3, employing Odds Ratios (OR) for categorical outcomes and Mean Difference (MD) for continuous variables.
Key Results
The meta-analysis revealed several significant clinical advantages for the laser-based approach:
Enhanced Surgical Safety
The use of laser energy effectively eliminated the electrical stimulation of the obturator nerve. HOLRBT demonstrated a significantly lower incidence of:
- Obturator nerve reflex: OR = 0.06
- Bladder perforation: OR = 0.15
- Bladder irritation: OR = 0.45
Improved Patient Recovery
HOLRBT contributed to a faster post-operative recovery phase. On average, patients in the HOLRBT group experienced:
- Shorter catheterization times: MD = -1.02 days
- Reduced hospital stays: MD = -1.11 days
Long-term Oncological Efficacy
While 1-year recurrence rates were comparable between the two methods, HOLRBT showed a superior outcome at the 2-year mark. The 2-year recurrence rate was 26.1% for HOLRBT versus 34.3% for TURBT (OR = 0.69). This suggests that laser resection may facilitate a more precise "en bloc" removal of the tumor, potentially leading to cleaner margins.
No significant differences were found regarding operation time or the incidence of urethral strictures.
Discussion and Limitations
The findings suggest that HOLRBT is a safer and potentially more effective alternative to traditional TURBT, particularly in reducing perioperative complications and long-term recurrence. However, several limitations must be considered. Most included studies were retrospective or cohort-based, with only one RCT, which introduces potential bias. Additionally, there was high statistical heterogeneity in recovery times, likely reflecting differences in institutional protocols and surgeon experience.
Conclusion
HOLRBT appears to be a superior choice for treating NMIBC, offering significant improvements in safety and recovery speed without compromising surgical efficiency. Future large-scale, multi-center randomized controlled trials are needed to further standardize the procedure and validate these findings across diverse patient populations.
Summary updated